WBBM Radio Chicago on MSN3 天
FDA approves new treatment for schizophrenia
With Thursday approval from the U.S. Food and Drug Administration for Cobenfy, adults living with schizophrenia will have ...
Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...
CONSTELLA is also indicated for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). About the linaclotide study 3 ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...
US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...
Constipation is a common condition, especially among older adults and the cause is often multifactorial. Treatment of older adults is often complicated by comorbidities including polypharmacy and ...
Certain foods and drinks can help relieve constipation by promoting digestion and improving bowel regularity. Herbal teas are also effective remedies for constipation. These teas work by relaxing ...
About 16% of adults have constipation and the numbers nearly double for people over 60 ... The review was published recently in the journal Clinical Gastroenterology and Hepatology. The cure for ...